By Finance Pulse in Critical —

Novartis Hit with Whistleblower Lawsuit Over Gilenya Kickbacks

Novartis is facing legal scrutiny as a whistleblower lawsuit alleges the company paid kickbacks to promote its MS drug Gilenya, impacting the healthcare sector.

A sleek, modern illustration featuring a gavel and medical pill bottle, symbolizing the intersection
Novartis Hit with Whistleblower Lawsuit Over Gilenya Kickbacks

Novartis faces a whistleblower lawsuit for allegedly paying kickbacks to promote its MS drug Gilenya, with implications for the healthcare sector.

Source